Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00291161 · ClinicalTrials.gov registry record · NA

Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
994
Enrollment target

NCT00291161: Completed NA study, sponsored by VA Office of Research and Development.

NCT00291161 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 994 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00291161, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
994 participants
Enrollment target

Study Summary

Background: Partners in Dementia Care (PDC) is a care coordination and support service intervention for veterans with dementia and their family caregivers, delivered through partnerships between VA medical centers and local Alzheimer's Association Chapters. PDC was designed to be a feasible and practical intervention to integrate health, community, and support services. PDC has a standardized protocol for care coordination and support services, including guidelines for care plan assessment, care plan development and implementation, ongoing monitoring, and reassessment. It also offers a structured training curriculum for providers and an operations manual for uniform implementation. Objectives: The primary objective was to test the impact of PDC on outcomes for veterans with dementia and family caregivers. Two specific research objectives and corresponding hypotheses were addressed: 1. To test the impact of PDC on three categories of outcomes: psychosocial well-being outcomes (patient and caregiver effects); health care service use (patient effects only); and health care cost (patient effects only). HI:PDC, compared to usual care, will improve psychosocial well-being for patients with dementia and their caregivers. H2:PDC, compared to usual care, will reduce health care service use for patients with dementia. H3:PDC is preferred to usual care based on cost-benefit analyses. H4:The PDC intervention will be more effective in improving psychosocial well-being and reducing health care service use for patients and caregivers dealing with more severe patient impairment (e.g., cognitive status, functional status, and level of problem behaviors). 2. To evaluate the impact of PDC on role and intra-psychic strains caused by dementia and its care (patient and caregiver effects). H5a:PDC, compared to usual care, will decrease patient role and intra-psychic strain. H5b:PDC, compared to usual care, will decrease caregiver role and intra-psychic strain. H6:The PDC intervention wil

Primary Outcome

The following outcomes were measured in Caregivers via scales administered to each caregiver: Unmet need (range=0 to 39, higher meaning more unmet needs); Role captivity (range=0-9, higher indicating greater role captivity); Physical health strain (range=0-9, higher indicating greater health strain); Relationship strain (range=0-18, higher indicating greater relationship strain); Depression (range=0-22, higher indicating greater depression); Caregiver support service use (the number of support s

Interventions

  • BEHAVIORAL Partners in Dementia Care

Trial Details

FieldValue
Enrollment Target 994 participants
Start Date 2006-12
Est. Completion 2011-02
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT00291161 record still lists

NCT00291161 is an interventional study that assigns participants to a tested intervention. The registered 994 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 0 conditions, and to 1 intervention - of which Partners in Dementia Care is the first listed.

NCT00291161 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00291161 about?

NCT00291161 is a clinical study titled "Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters". Background: Partners in Dementia Care (PDC) is a care coordination and support service intervention for veterans with dementia and their family caregivers, delivered through partnerships between VA medical centers and local Alzheimer's Association Chapters. PDC was designed to be a feasible and prac...

What is the current status of trial NCT00291161?

This trial is currently completed. It is a NA study. The enrollment target is 994 participants. The study started on 2006-12. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00291161?

The interventions under investigation include: Partners in Dementia Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00291161?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00291161's enrollment target sits among peer trials

994 121st of 2000 higher than 1,880 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05437575 · 994 participants · Phase 3

    Prehospital Analgesia INtervention Trial (PAIN)

  • NCT06671704 · 994 participants · NA

    GC-PRO Intervention

  • NCT07005024 · 996 participants · Phase 3

    DOAC - Dosing Options in AntiCoagulation Prophylaxis

  • NCT05987241 · 992 participants · Phase 2

    Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00291161, the US trial registry maintained by the National Library of Medicine. NCT00291161 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.